KC Pharma
Generated 5/10/2026
Executive Summary
KC Pharmaceuticals, Inc. is a leading private label manufacturer of over-the-counter (OTC) eye care and contact lens care solutions in North America. Based in Kansas City and founded in 2005, the company operates a large, FDA-inspected manufacturing campus focused on aseptic fill manufacturing. It offers a comprehensive portfolio including eye drops, ointments, and lens care solutions to major retailers under their private labels. As a private company, KC Pharma benefits from strong relationships with retail partners and the growing demand for affordable OTC eye care products. The company's scalable manufacturing capabilities and regulatory compliance position it well for continued growth. However, as a private entity, financial details and near-term growth drivers are not publicly disclosed, introducing uncertainty around valuation and market share dynamics.
Upcoming Catalysts (preview)
- Q2 2027New Private Label Contracts with Major Retailers75% success
- Q4 2026Manufacturing Capacity Expansion60% success
- Q1 2027Launch of New OTC Eye Care Product Line80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)